click below
click below
Normal Size Small Size show me how
Neurotransmitters
PNS Exam 2
| Question | Answer |
|---|---|
| ACh (nic) Agonist | Nicotine |
| ACh (nic) Antagonist | Curare, Rabies |
| ACh (nic) Potentiator | Acetylcholinesterase inhibitors: Physostigmine, Neostigmine, Nerve gas (irrev.) |
| ACh (nic) Inhibitor | Acetylcholinesterase |
| ACh (nic) Disease | Myasthenia gravis |
| ACh (musc) Agonist | Muscarine |
| ACh (musc) Antagonist | Atropine, Belladonna |
| ACh (musc) Inhibitor | Acetylcholinesterase |
| ACh nicotinic receptor channel type | (non-specific Na+/K+) fEPSP |
| ACh muscarinic receptor channel type | (M1+ M2- M3+) all slow potentials |
| GABA receptor type | GABAa (specific Cl- channels) fIPSP |
| GABA Agonist | GABA |
| GABA Antagonist | Bicuculline, Picrotoxin |
| GABA Potentiator | Benzo-diazapines, Valerian, Barbituates, Valproic acid |
| GABA Inhibitor | GABA T |
| ACh (musc) Disease | Alzheimer's |
| GABA Disease | Epilepsy, Panic Anxiety |
| GLU receptor type | NMDA, AMPA (Na+/Ca++ channel)fEPSP, others |
| GLU Agonist | NMDA, AMPA, others |
| GLU Antagonist | Channel blockers: Ketamine, PCP |
| GLU Potentiator | SP (in nociception models) |
| GLU Disease | Huntington's disease |
| SP receptor type | NK1 (neurokinin1): sEPSP |
| SP Agonist | SP |
| SP Potentiator | Capsaicin |
| SP Disease | Nociception modulation |
| ENK receptor type | Mu, Delta, and Kappa (all g-protein mediated) sIPSP |
| ENK Agonist | Opioids, Morphine, Heroin, Percodan, Oxycotin, ect |
| ENK Antagonist | Naloxone, Narcan |
| ENK Disease | Nociception, analgesia, respiratory depression, euphoria, constipation. |
| 5-HT receptor type | 5-HT1,fIPSP 5-HT2B, sEPSP vaso-constriction, platelet aggregation; 5-HT3, fEPSP |
| 5-HT Agonist | Lysergic Acid |
| 5-HT Potentiator | SSRIs: Prozac, Zoloft, Paxil, Wellbutrin, etc MAO inhibitors: pargyline (Deprenyl, selegiline) |
| 5-HT Inhibitor | MAO |
| 5-HT Disease | Nociception modulation (descending noxious inhibitory control); Sleep; emotional states; depression |
| DA receptor type | D1, sIPSP; D2, sEPSP, others |
| DA antagonist | Haloperidol (Haldol); Thorazine: antipsychotics |
| DA Potentiators | MAO inhibitors: pargyline (Deprenyl, selegiline) L-DOPA; Amphetamines block reuptake |
| DA Disease | Parkinsons |